BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31206525)

  • 1. Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice.
    Arakawa K; Ishigami T; Nakai-Sugiyama M; Chen L; Doi H; Kino T; Minegishi S; Saigoh-Teranaka S; Sasaki-Nakashima R; Hibi K; Kimura K; Tamura K
    PLoS One; 2019; 14(6):e0218096. PubMed ID: 31206525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical Activation or Genetic Absence of ClC-2 Alters Tight Junctions During Experimental Colitis.
    Jin Y; Pridgen TA; Blikslager AT
    Inflamm Bowel Dis; 2015 Dec; 21(12):2747-57. PubMed ID: 26332307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic stress and intestinal permeability: Lubiprostone regulates glucocorticoid receptor-mediated changes in colon epithelial tight junction proteins, barrier function, and visceral pain in the rodent and human.
    Zong Y; Zhu S; Zhang S; Zheng G; Wiley JW; Hong S
    Neurogastroenterol Motil; 2019 Feb; 31(2):e13477. PubMed ID: 30284340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe
    Zhu L; Zhang D; Zhu H; Zhu J; Weng S; Dong L; Liu T; Hu Y; Shen X
    Atherosclerosis; 2018 Jan; 268():117-126. PubMed ID: 29202334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-/- mice--role of intestinal permeability and macrophage activation.
    Ghosh SS; Bie J; Wang J; Ghosh S
    PLoS One; 2014; 9(9):e108577. PubMed ID: 25251395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.
    Kato T; Honda Y; Kurita Y; Iwasaki A; Sato T; Kessoku T; Uchiyama S; Ogawa Y; Ohkubo H; Higurashi T; Yamanaka T; Usuda H; Wada K; Nakajima A
    PLoS One; 2017; 12(4):e0175626. PubMed ID: 28410406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lubiprostone Induces Claudin-1 and Protects Intestinal Barrier Function.
    Nishii N; Oshima T; Li M; Eda H; Nakamura K; Tamura A; Ogawa T; Yamasaki T; Kondo T; Kono T; Tozawa K; Tomita T; Fukui H; Miwa H
    Pharmacology; 2020; 105(1-2):102-108. PubMed ID: 31536982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe-/- Mice.
    Li J; Lin S; Vanhoutte PM; Woo CW; Xu A
    Circulation; 2016 Jun; 133(24):2434-46. PubMed ID: 27143680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone.
    Moeser AJ; Nighot PK; Engelke KJ; Ueno R; Blikslager AT
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G647-56. PubMed ID: 17053162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alleviation of cholestatic liver injury and intestinal permeability by lubiprostone treatment in bile duct ligated rats: role of intestinal FXR and tight junction proteins claudin-1, claudin-2, and occludin.
    Safari F; Sharifi M; Talebi A; Mehranfard N; Ghasemi M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2009-2022. PubMed ID: 36897372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
    Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-34c and PlncRNA1 mediated the function of intestinal epithelial barrier by regulating tight junction proteins in inflammatory bowel disease.
    Chen T; Xue H; Lin R; Huang Z
    Biochem Biophys Res Commun; 2017 Apr; 486(1):6-13. PubMed ID: 28153728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of soybean agglutinin on intestinal barrier permeability and tight junction protein expression in weaned piglets.
    Zhao Y; Qin G; Sun Z; Che D; Bao N; Zhang X
    Int J Mol Sci; 2011; 12(12):8502-12. PubMed ID: 22272087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lubiprostone protects esophageal mucosa from acid injury in porcine esophagus.
    Krüger L; Pridgen TA; Taylor ER; Garman KS; Blikslager AT
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G613-G623. PubMed ID: 32068440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct gene signatures in aortic tissue from ApoE-/- mice exposed to pathogens or Western diet.
    Kramer CD; Weinberg EO; Gower AC; He X; Mekasha S; Slocum C; Beaulieu LM; Wetzler L; Alekseyev Y; Gibson FC; Freedman JE; Ingalls RR; Genco CA
    BMC Genomics; 2014 Dec; 15(1):1176. PubMed ID: 25540039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ; Waseem TC; Galkina EV
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Role of Basolateral ClC-2 Channels in the Regulation of Duodenal Anion Secretion in Mice.
    Du C; Liu J; Wan H; Dong H; Zhao X
    Dig Dis Sci; 2019 Sep; 64(9):2527-2537. PubMed ID: 30874987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Regulatory Effects of Corticotropin-Releasing Factor on Tight Junction-Related Intestinal Epithelial Permeability are Partially Mediated by CK8 Upregulation.
    Yue H; Bin L; Chaoying C; Meng Z; Meng L; Xi W
    Cell Physiol Biochem; 2017; 44(3):1161-1173. PubMed ID: 29179184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short Chain Fatty Acids Effect on Chloride Channel ClC-2 as a Possible Mechanism for Lubiprostone Intestinal Action.
    Catalán MA; Julio-Kalajzić F; Niemeyer MI; Cid LP; Sepúlveda FV
    Cells; 2020 Jul; 9(8):. PubMed ID: 32722648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.
    Jahagirdar R; Zhang H; Azhar S; Tobin J; Attwell S; Yu R; Wu J; McLure KG; Hansen HC; Wagner GS; Young PR; Srivastava RA; Wong NC; Johansson J
    Atherosclerosis; 2014 Sep; 236(1):91-100. PubMed ID: 25016363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.